← FDA Drug Approvals (Drugs@FDA)

LEQVIO

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2021-12-22

Drug application

FDA Application #

NDA214012

Application type

New Drug Application

Brand name

LEQVIO

Generic name

INCLISIRAN

Active ingredients

INCLISIRAN SODIUM

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2021-12-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown